Selective inhibition of human translation termination by a drug-like compound
The drug-like compound PF846 and its derivatives inhibit the translation of specific mRNAs by the human ribosome. Here the authors show how PF846 arrests translation at the stop codon by slowing hydrolysis of the protein nascent chain at the ribosome P-site tRNA by eukaryotic release factor 1 (eRF1)...
Main Authors: | Wenfei Li, Stacey Tsai-Lan Chang, Fred. R. Ward, Jamie H. D. Cate |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-10-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18765-2 |
Similar Items
-
(Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like Compounds
by: Leonid A. Stolbov, et al.
Published: (2019-12-01) -
Human-like eukaryotic translation initiation factor 3 from Neurospora crassa.
by: M Duane Smith, et al.
Published: (2013-01-01) -
Engineering a potential protein drug, PTD-α-sarcin that inhibits translation
by: Yea-Lan Chang, et al.
Published: (2006) -
Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines
by: Shen Mingyun, et al.
Published: (2012-11-01) -
Historeceptomic fingerprints for drug-like compounds
by: Evgeny eShmelkov, et al.
Published: (2015-12-01)